Retatrutide is a triple-receptor agonist, meaning it simultaneously activates three distinct hormone receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the glucagon receptor
Pretty much anything that has the Glycyrrhiz
This intermediate size often provides high specificity for their targets while maintaining reasonable manufacturing feasibility
It details how these compounds interact with immune cells to boost defenses, reduce inflammation, and speed up tissue repair
1 You may have heard of Ozempic, Monjauro, Zepbound or Wegovyall brand names for different types of GLP-1 drugs
Therefore, thorough examination of GLP-1R expression with different specific antibodies and various validation methods in large numbers of PTC samples is warranted